• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 vaccine trials and sex-disaggregated data.新冠病毒疫苗试验与按性别分类的数据。
Expert Rev Vaccines. 2022 Mar;21(3):285-288. doi: 10.1080/14760584.2022.2015331. Epub 2021 Dec 19.
2
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
3
COVID-19 vaccines surveillance in France: a global response to a major national challenge.法国的新冠疫苗监测：对一项重大国家挑战的全球应对。
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100866. doi: 10.1016/j.accpm.2021.100866. Epub 2021 Apr 22.
4
Host factors and vaccine efficacy: Implications for COVID-19 vaccines.宿主因素与疫苗效力：对 COVID-19 疫苗的启示。
J Med Virol. 2022 Apr;94(4):1330-1335. doi: 10.1002/jmv.27485. Epub 2021 Dec 7.
5
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?在研的 SARS-CoV-2 疫苗：我们处于什么阶段？
Adv Drug Deliv Rev. 2021 May;172:314-338. doi: 10.1016/j.addr.2021.01.014. Epub 2021 Jan 20.
6
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.一种基于重组串联重复二聚体 RBD 的蛋白亚单位疫苗（ZF2001）在成年人中的安全性和免疫原性：两项随机、双盲、安慰剂对照、1 期和 2 期临床试验。
Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24.
7
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.SARS-CoV-2 候选疫苗：III 期临床试验的预期和疫苗批准后的建议。
Viruses. 2020 Dec 31;13(1):54. doi: 10.3390/v13010054.
8
The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.性别的可能作用：作为脂质纳米医学 COVID-19 疫苗研发和管理中重要因素的探讨。
Mol Pharm. 2021 Jun 7;18(6):2448-2453. doi: 10.1021/acs.molpharmaceut.1c00291. Epub 2021 May 13.
9
The way of SARS-CoV-2 vaccine development: success and challenges.SARS-CoV-2 疫苗的研发之路：成功与挑战。
Signal Transduct Target Ther. 2021 Nov 9;6(1):387. doi: 10.1038/s41392-021-00796-w.
10
Sex-based differences in severity and mortality in COVID-19.性别差异与 COVID-19 的严重程度和死亡率。
Rev Med Virol. 2021 Nov;31(6):e2223. doi: 10.1002/rmv.2223. Epub 2021 Mar 1.

引用本文的文献

1
Changes in Local and Systemic Adverse Effects following Primary and Booster Immunisation against COVID-19 in an Observational Cohort of Dutch Healthcare Workers Vaccinated with BNT162b2 (Comirnaty).在接种BNT162b2（Comirnaty）疫苗的荷兰医护人员观察队列中，初次和加强免疫COVID-19后局部和全身不良反应的变化。
Vaccines (Basel). 2023 Dec 29;12(1):39. doi: 10.3390/vaccines12010039.
2
Overlooked sex and gender aspects of emerging infectious disease outbreaks: Lessons learned from COVID-19 to move towards health equity in pandemic response.新发传染病疫情中被忽视的性别因素：从新冠疫情中吸取的经验教训，以推动大流行应对中的健康公平。
Front Glob Womens Health. 2023 Feb 20;4:1141064. doi: 10.3389/fgwh.2023.1141064. eCollection 2023.
3
COVID-19 complications in males and females: recent developments.COVID-19 并发症在男性和女性中的表现：最新进展。
J Comp Eff Res. 2022 Jun;11(9):689-698. doi: 10.2217/cer-2022-0027. Epub 2022 May 5.

本文引用的文献

1
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.以色列接种 BNT162b2 mRNA 疫苗后出现心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
2
Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis.新冠疫苗效力的性别差异：一项系统评价与荟萃分析
Vaccines (Basel). 2021 Jul 27;9(8):825. doi: 10.3390/vaccines9080825.
3
Lack of consideration of sex and gender in COVID-19 clinical studies.COVID-19 临床研究中对性别因素的考虑不足。
Nat Commun. 2021 Jul 6;12(1):4015. doi: 10.1038/s41467-021-24265-8.
4
Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the Sex and Gender Equity in Research (SAGER) guidelines.COVID-19临床研究报告不充分：研究中的性别与公平性（SAGER）指南的新依据
BMJ Glob Health. 2021 Apr;6(4). doi: 10.1136/bmjgh-2021-004997.
5
Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.性别特异性年龄和体重指数对医护人员季节性流感疫苗抗体反应的影响。
Vaccine. 2022 Mar 8;40(11):1634-1642. doi: 10.1016/j.vaccine.2021.02.047. Epub 2021 Mar 4.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
9
The "sex gap" in COVID-19 trials: a scoping review.新冠病毒疾病试验中的“性别差异”：一项范围综述
EClinicalMedicine. 2020 Dec;29:100652. doi: 10.1016/j.eclinm.2020.100652. Epub 2020 Nov 30.
10
Making pharmaceutical research and regulation work for women.促进女性参与药物研发和监管工作。
BMJ. 2020 Oct 27;371:m3808. doi: 10.1136/bmj.m3808.

COVID-19 vaccine trials and sex-disaggregated data.

作者信息

Hussain Musaddique, Fatima Mehwish, Muhammad Iqbal Shahid, Asif Muhammad, Saadullah Malik, Mukhtar Imran, Ahmad Khan Imran, Parveen Sajida, Fayyaz Tehreem, Shabbir Najia, Kanwal Aisha, Shaukat Saira, Fatima Mobeen, Ikram Nadia, Majeed Abdul, Parveen Farzana, Tariq Muhammad, Barkat Muhammad Qasim, Zeng Ling-Hui, Wu Ximei

机构信息

Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

出版信息

Expert Rev Vaccines. 2022 Mar;21(3):285-288. doi: 10.1080/14760584.2022.2015331. Epub 2021 Dec 19.

DOI:10.1080/14760584.2022.2015331
PMID:34894982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8726001/
Abstract
摘要